Devlin Jodi - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Devlin Jodi
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-03-11
Sale
2026-03-20
4:25 pm
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of Clinical Operations
3,207$4.107$13,17197,364
(Direct)
View
2025-05-19
Sale
2025-05-21
5:31 pm
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of Clinical Operations
4,764$5.18$24,67852,764
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-11-24
Option Award
2025-11-25
3:56 pm
N/A
2025-11-23
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of Clinical Operations
150,000$0564,321
(Direct)
View
2025-05-19
Option Award
2025-05-21
5:31 pm
N/A
N/A
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of Clinical Operations
24,131$5.1852,764
(Direct)
View
2025-02-18
Option Award
2025-02-19
5:37 pm
N/A
N/A
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of Clinical Operations
5,272$033,397
(Direct)
View
2025-01-27
Option Award
2025-01-29
6:00 pm
N/A
2035-01-26
TriSalus Life Sciences Inc.TLSIDevlin Jodi
Chief of COMMERC. OPERATIONS
74,375$091,875
(Direct)
View
2024-02-12
Option Award
2024-02-14
6:19 pm
N/A
2034-02-11
TriSalus Life Sciences Inc.TLSIDevlin Jodi
PRESIDENT, COMMERC. OPERATIONS
122,500$0122,500
(Direct)
View
2023-08-30
Option Award
2023-08-31
9:04 pm
N/A
2033-08-29
TriSalus Life Sciences Inc.TLSIDevlin Jodi
President, Therapeutics
195,000$0195,000
(Direct)
View